Lucia Del Mastro

39PUBLICATIONS
296CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsInnate immunityLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Mar 06, 2026
Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Roberto Buonaiuto, Aldo Caltavituro, Rossana Di Rienzo

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Dec 29, 2025
OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.

Barbara Pistilli, Meritxell Bellet Ezquerra, Lucia Del Mastro

|Sep 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.

Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni

|Sep 13, 2025
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.

Giuseppe Di Grazia, Arianna Dri, Angela Grieco

Pageof 7

Frequent Collaborators

15 joint publications

Fabio Puglisi

14 joint publications

Matteo Lambertini

8 joint publications

Filippo Montemurro

8 joint publications

Giampaolo Bianchini